DPP4 and prostate carcinoma: For example, suppression or down-regulation of DPP4 promotes prostate cancer progression via reduced degradation of its substrate CXCL12, leading to enhanced signalling via CXCR4 and increased invasion and metastatic spread to peripheral organs in vivo [40,41].